My doubt is about using MCF-7 cell line as a model for assessing the toxicity of fibrils. My fibrils are toxic to this cell line and the compound under study is ameliorating the toxicity. Therefore, can it be concluded that the compound is less toxic or more toxic because the cell line under study is a cancer cell line? Need to clear this doubt at the earliest..